Contact UsCareersMediaScienceContact UsHomeOur Voice Pfizer announces recipients of research grants focused on transthyretin amyloid cardiomyopathy inHomeOur VoiceAdvancing Cancer Care in Canada Through Collaborative InnovationThursday, December 12, 2024The future of cancer care in Canada is poised to undergo a remarkable transformation, driven by a surge of scientific advances and a renewed commitment to ensuring equitable access for all patients. 
As a global leader in oncology, Pfizer has been at the forefront of developing groundbreaking cancer therapies for over two decades. Nearly 40% of the company's entire R&D investment is dedicated to advancing transformative oncology treatments, from small molecule targeted therapies to next-generation biologics like bispecific antibodies and antibody-drug conjugates. This focus has enabled Pfizer to pioneer several innovations across multiple cancer types.
However, notes Cynthia Di Lullo, Pfizer Canada’s Oncology Lead, sometimes the scientific innovations happening in cancer research are only half the battle. “Barriers to access can present significant hurdles to many patients who are trying to benefit from these advancements in a timely manner,” she asserts.
For example, the unique requirements of advanced therapies, such as CAR-T and bispecific antibodies, are putting unprecedented demands on Canada's healthcare systems. From the need for specialized administration and monitoring capabilities, to the complexities of coordinating multidisciplinary care, these innovations are testing the limits of existing infrastructure and resources. 
"Simply put, our healthcare systems were not designed with these transformative therapies in mind," says Cynthia.
Addressing these systemic challenges will require a collaborative effort across all healthcare stakeholders - from researchers and clinicians, to policymakers, payers and patient advocates. "No one stakeholder can solve these challenges alone," Cynthia emphasizes. "It will take a collective effort to transform the cancer care ecosystem to meet the emerging needs required by these types of innovative therapies."
This means exploring innovative care delivery models that can accommodate the specialized requirements of advanced therapeutics. It means investing in digital infrastructure and workforce development to enhance system capacity and capabilities. And crucially, it means ensuring equitable access, so that all patients can benefit from these new treatment modalities.
 
Pfizer is already actively engaged in many of these collaborative efforts, working together with healthcare providers, payers and patient groups to design solutions that meet the needs of the patient. However, there is much more work to be done. 
"The promise of the next generation of cancer treatments will only be realized through a shared commitment to innovation - not just in the lab, but across every aspect of the healthcare landscape," stresses Cynthia.
Together, the cancer care ecosystems of the future can be built - ones that are prepared to deliver on the full potential of scientific innovation and provide every patient touched by this disease the care and support they deserve.
At Pfizer, we believe that time is life. And for people living with cancer, each day matters. Cancer isn’t slowing down – so it’s time we speed up.
Our Voice
It’s National Immunization Awareness Month. Here Are Some Tips To Help
Separate Fact From Fiction.
Where Compassion Leads: Patricia’s Lifelong Commitment to Community
Finding Joy on the Road: Curtis’s Journey with the Friends for Life Bike Rally
Pfizer Supports Indigenous Pharmacy Student's Pursuit of Culturally-Informed Care
Unlocking the Full Potential of Innovation in Canada: A Pathway to Healthier Lives and Stronger Communities
Pfizer Canada's Clinical Trials: Advancing Medical Innovation and Improving Patient Outcomes
Pfizer Canada Leads the Way in Advancing Inflammatory Bowel Disease Care
Wishing Love and Health to all Mothers
The value of vaccines in protecting our health and well-being
Reframing Cancer as Part of the Story
This World Health Day: Protecting Infants through Maternal Vaccination
Pfizer Canada Proud to Support Innovative Mobile Health Clinic for Vulnerable Children in Montreal
Pfizer's Medical Affairs Team: Advancing Science and Improving Patient Care
Introducing the Faces of Pfizer Fighting Against Cancer in Canada
Empowering Growth at Pfizer Canada: The Transformative Impact of Group Mentorship
Advancing Cancer Care in Canada Through Collaborative Innovation
Giving A Hand at the Paralympics - A Volunteer Story
Exploring the Future of Canada’s Digital Health with Pfizer’s First Healthcare Hub Winners
World Pneumonia Day: Supporting Vaccination Efforts Across Canada
Empowering Early Breast Cancer Detection through Innovation
Meet Jacquie Baker, Recipient of the CCS-Pfizer ATTR-CM 2023 Research Fellowship Award
Culturally Responsive Health Care: Wellness Wheel Clinical Team and their Approach to Care with First Nations Communities
Caring for Aging Parents with Compassion and Wisdom
Pfizer’s Commitment to Indigenous Health Research
Celebrating World Pharmacist Day: How PharmaGuide Empowers Pharmacists to Help Enhance Patient Care in Canada
Counterfeit Medicines: A Serious Threat to Patient Safety
Paralympic Hopeful Allison Lang Shares Her Story of Disability Advocacy and Excellence in Sport
The importance of data this National Immunization Awareness Month
Our Voice
About UsOur ProductsHelping CommunitiesOur Voice Suppliers Distribution ChannelPfizer WorldwideMedia CentreTerms Of Use Careers Healthcare ProfessionalsContact UsPrivacy PolicyCopyright © Pfizer Canada 2025 All rights reserved. The information is intended only for residents of Canada. ® Pfizer Inc, used under license